Abstract
D-limonene is recognized as a potential chemotherapeutic agent, however, the details of this mechanism remain unclear. In this study, we investigated the effects of d-limonene on colon cancer cell viability and its potential mechanism of action in vitro. After 48 h of treatment, d-limonene suppressed the viability of LS174T cells in a dose-dependent manner and caused a dose-dependent apoptotic cell death. D-limonene activated caspase-3 and -9 and PARP cleavage in a dose-dependent manner. Moreover, an increase in Bax protein and cytosol cytochrome c from mitochondria and a decrease in bcl-2 protein were observed following treatment with d-limonene. In addition, d-limonene decreased the levels of p-Akt (Ser473), p-Akt (Thr308) and p-GSK-3β (Ser9), suggesting that d-limonene induced apoptosis via the mitochondrial death pathway and the suppression of the PI3K/Akt pathway.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anticarcinogenic Agents / pharmacology*
-
Apoptosis / drug effects*
-
Blotting, Western
-
Caspase 3 / metabolism
-
Cell Proliferation
-
Colonic Neoplasms / drug therapy
-
Colonic Neoplasms / metabolism
-
Colonic Neoplasms / pathology*
-
Cyclohexenes / pharmacology*
-
Cytochromes c / metabolism
-
Cytosol / drug effects
-
Cytosol / metabolism
-
Flow Cytometry
-
Glycogen Synthase Kinase 3 / metabolism
-
Glycogen Synthase Kinase 3 beta
-
Humans
-
Limonene
-
Mitochondria / drug effects
-
Mitochondria / metabolism
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors*
-
Proto-Oncogene Proteins c-akt / metabolism
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
Terpenes / pharmacology*
-
Tumor Cells, Cultured
-
bcl-2-Associated X Protein / metabolism
Substances
-
Anticarcinogenic Agents
-
Cyclohexenes
-
Proto-Oncogene Proteins c-bcl-2
-
Terpenes
-
bcl-2-Associated X Protein
-
Cytochromes c
-
Limonene
-
GSK3B protein, human
-
Glycogen Synthase Kinase 3 beta
-
Proto-Oncogene Proteins c-akt
-
Glycogen Synthase Kinase 3
-
Caspase 3